Posttransplant Malignancy.

Document Type

Article

Publication Date

2-1-2019

Institution/Department

Nephrology & Transplantation

Journal Title

The Surgical clinics of North America

MeSH Headings

Humans, Immunosuppression, Neoplasms, Organ Transplantation, Risk Factors

Abstract

Posttransplant malignancy is a leading cause of death after solid organ transplantation (SOT). Recipients of SOT are at significantly higher risk of multiple cancers compared with the general population, most notably nonmelanoma skin cancer and posttransplant lymphoproliferative disorders. Risk factors for posttransplant malignancy include history of malignancy, immunosuppression, oncogenic viral infections, sun exposure, and disease-specific associations. Early detection and treatment of malignancies can improve survival.

ISSN

1558-3171

First Page

49

Last Page

64

Share

COinS